SMTL ID : 2zzc.1 (1 other biounit)

Crystal structure of NADP(H):human thioredoxin reductase I

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

homo-dimer

Ligands

2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)

FAD.1: 35 residues within 4Å: Chain A: I.32, G.33, G.35, S.36, G.37, L.55, D.56, F.57, V.58, G.71, T.72, C.73, V.76, G.77, C.78, K.81, A.144, Y.145, G.146, A.174, T.175, G.176, S.194, F.198, R.307, I.314, G.347, D.348, E.355, L.356, T.357, P.358 Chain B: H.486, P.487 Ligands: NAP.2 23 PLIP interactions: 22 interactions with chain A, 1 interactions with chain B Hydrophobic interactions: A:T.72, A:F.198 Hydrogen bonds: A:G.34, A:S.36, A:S.36, A:G.37, A:G.38, A:F.57, A:T.72, A:T.72, A:T.72, A:C.73, A:K.81, A:G.146, A:G.146, A:D.348, A:E.355, A:T.357, A:T.357, B:H.486 Water bridges: A:T.59, A:R.307, A:D.348 FAD.3: 37 residues within 4Å: Chain A: H.486, P.487 Chain B: I.32, G.33, G.34, G.35, S.36, G.37, L.55, D.56, F.57, G.71, T.72, C.73, V.76, G.77, C.78, K.81, A.144, Y.145, G.146, A.174, T.175, G.176, S.194, F.198, V.215, R.307, I.314, G.347, D.348, E.355, L.356, T.357, P.358, F.389 Ligands: NAP.4 27 PLIP interactions: 24 interactions with chain B, 3 interactions with chain A Hydrophobic interactions: B:T.72, B:F.198, B:V.215 Hydrogen bonds: B:G.34, B:S.36, B:S.36, B:G.37, B:F.57, B:G.71, B:T.72, B:C.73, B:K.81, B:G.146, B:G.146, B:D.348, B:E.355, B:T.357, B:T.357, B:T.357, A:H.486 Water bridges: B:G.35, B:T.59, B:T.72, B:T.72, B:R.307, A:H.486, A:H.486

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.2: 22 residues within 4Å: Chain A: K.81, L.182, V.210, G.211, A.212, S.213, Y.214, V.215, E.218, R.235, S.236, R.240, V.266, A.304, I.305, G.306, R.307, E.355, L.356, T.386, T.387 Ligands: FAD.1 24 PLIP interactions: 24 interactions with chain A Hydrophobic interactions: A:Y.214, A:V.215 Hydrogen bonds: A:K.81, A:A.212, A:A.212, A:S.213, A:V.215, A:E.218, A:R.235, A:S.236, A:S.236, A:G.306, A:T.386 Water bridges: A:Y.214, A:Y.214, A:A.216, A:A.216, A:I.305, A:R.307, A:T.387 Salt bridges: A:R.235, A:R.240 pi-Stacking: A:Y.214 pi-Cation interactions: A:R.235 NAP.4: 22 residues within 4Å: Chain B: K.81, L.182, V.210, G.211, A.212, S.213, Y.214, V.215, E.218, R.235, S.236, R.240, V.266, A.304, I.305, G.306, R.307, E.355, L.356, T.387, F.389 Ligands: FAD.3 17 PLIP interactions: 17 interactions with chain B Hydrophobic interactions: B:Y.214, B:V.215 Hydrogen bonds: B:A.212, B:A.212, B:S.213, B:V.215, B:E.218, B:R.235, B:S.236, B:I.237, B:G.306 Water bridges: B:R.235, B:R.240 Salt bridges: B:R.235, B:R.240 pi-Stacking: B:Y.214 pi-Cation interactions: B:R.235

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lo, Y.C. et al., Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1. J.Inorg.Biochem. (2009)

Release Date

2009-08-18

Peptides

Thioredoxin reductase 1, cytoplasmic: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Thioredoxin reductase 1, cytoplasmic

Related Entries With Identical Sequence